Peripheral Arterial Disease Trial, Recruiting (NCT06318767)

Peripheral Arterial Disease Trial, Recruiting NCT06318767 Sponsor: Centre Hospitalier Universitaire, Amiens Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06318767 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 18 years old
People who are willing and able to sign a written consent form agreeing to take part
People who have been diagnosed with critical limb ischemia caused by atherosclerosis (a condition where narrowed arteries severely reduce blood flow to the legs, causing rest pain and/or wounds or tissue death)
People whose blood flow measurements in the affected limb fall below certain low thresholds, as measured by specific tests of blood pressure and oxygen levels in the tissue (confirm with trial site)
People who are being treated or referred to CHU Amiens Picardie hospital and are considered suitable candidates for surgical procedures to restore blood flow

Who may not be able to join:

People whose reduced blood flow to the limbs is caused by a condition other than atherosclerosis
People who are not considered suitable candidates for the standard surgical procedure to restore blood flow
People whose life expectancy is estimated to be less than 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 22 88 72 89

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06318767

Sponsor: Centre Hospitalier Universitaire, Amiens

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 03 22 88 72 89

More information: https://clinicaltrials.gov/study/NCT06318767

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 18 years old
People who are willing and able to sign a written consent form agreeing to take part
People who have been diagnosed with critical limb ischemia caused by atherosclerosis (a condition where narrowed arteries severely reduce blood flow to the legs, causing rest pain and/or wounds or tissue death)
People whose blood flow measurements in the affected limb fall below certain low thresholds, as measured by specific tests of blood pressure and oxygen levels in the tissue (confirm with trial site)
People who are being treated or referred to CHU Amiens Picardie hospital and are considered suitable candidates for surgical procedures to restore blood flow

Who may not be able to join:

People whose reduced blood flow to the limbs is caused by a condition other than atherosclerosis
People who are not considered suitable candidates for the standard surgical procedure to restore blood flow
People whose life expectancy is estimated to be less than 3 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire, Amiens

Registry

ClinicalTrials.gov

Start date

7 March 2024

Est. completion

1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

occurrence of limb ischemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov